All News

Patients 60 years and older with gastrointestinal cancers who reported inadequate emotional support were more likely to have poorer physical and mental quality of life, although no effect was observed in overall survival.

Patients with unresectable hepatocellular carcinoma, a type of liver cancer, obtained a survival benefit over four years of follow-up with a treatment regimen of Imfinzi and Imjudo.

Patients with cancer undergoing immunotherapy treatment did not have increased hospitalizations or serious side effects after getting the flu shot.

Anticipating a cancer scan, I think back on my early encounters with cancer.

From country music star, Toby Keith, providing an update on his cancer to the Duchess of York announcing her diagnosis, here’s what’s happening in the oncology space this week.

The use of Reqorsa and Tecentriq may increase prognosis for patients with extensive-stage small cell lung cancer.

Taking five or more medications increased the risk of death, hospitalizations and ER visits in elderly patients with colorectal cancer.

A chemotherapy shortage is resulting in altered treatment plans for many patients with cancer. CURE® spoke with experts about what that means for patients — and what they can do about it.

After chemo treatment, my nails were like tree trunks — showing ages and environmental stress with ridges.

William S. Laird, author of the unflinching memoir “Not Me, Cancer,” speaks with CURE’s “Cancer Horizons” podcast about the decision to share his story and the importance of perseverance.

Opting for telehealth appointments can make a big financial difference for rural-residing patients receiving urologic cancer care.

Treatment with a CAR-M cell therapy plus Keytruda is being assessed in a phase 1 study in patients with HER2-overexpressed tumors.

Patients with depression or anxiety at the time of a diffuse large B-cell lymphoma diagnosis tended to have worse survival, recent research showed.

After reflecting on my own experience and speaking to others who also had cancer, here are 12 things I’ve learned about dealing with the disease.

Supervised exercise can help to improve the immune system for patients with myeloma, recent research showed.

Being overweight might improve overall survival and progression-free survival for patients with head and neck cancer undergoing chemoradiotherapy, recent research showed.

Recent research found that patients who supplemented their vitamin D intake tended to have improved colorectal cancer outcomes.

Kim Stuck, who was diagnosed with breast cancer last year, says she "couldn’t even imagine not having cannabis during that time."

I have a confession: I daydreamed of a “last hurrah” should my cancer treatment not work.

Findings from a recent study demonstrated that exposure to Agent Orange increased the risk for bladder cancer but did not affect the disease’s aggressiveness.

Patients 65 years and older treated with Venclexta, Imbruvica and Gazyva for CLL had similar rates of progression-free survival compared with those treated with Imbruvica and Gazyva.

An expert gives an overview of the treatment options for uveal melanoma, and why he considers hope to be an essential part of the care plan.

Eating a plant-rich low-carbohydrate diet for survivors of breast cancer leads to better longevity, according to recent research.

Lymphoma treatment came with a number of unexpected side effects for me, including a runny nose.

Singer-songwriter Andrew McMahon is not the same person he was before his leukemia diagnosis, and that’s OK, he said.

Studies show that eating a high-fat meal with Alecensa can benefit patients with lung cancer throughout recovery.

There was no major difference in progression-free survival between patients with relapsed/refractory chronic lymphocytic leukemia who were treated with Calquence or Brukinsa.

I experienced unexpected rewards of decluttering.

The TILVANCE-301trial, expected to be completed in 2030, is the latest study of what has been described as one of the “phenomenal discoveries in melanoma.”

The NALIRIFOX regimen of Onivyde plus 5-fluorouracil/leucovorin and oxaliplatin has been shown to have survival and disease progression benefits for patients with pancreatic cancer in a clinical trial setting.